Skip to main content
. 2020 Oct;98(4):433–444. doi: 10.1124/mol.120.119438

Fig. 3.

Fig. 3.

DOR agonists have been shown to be effective in models of acute and chronic migraine–associate pain (nitroglycerin), negative affect (conditioned place aversion), and aura (cortical spreading depression), as well as in models of posttraumatic headache and medication overuse headache (MOH) related to sumatriptan or morphine (OIH).